The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
Somatostatin Analogs in Clinical Practice: A Review
Open accessAbstract
Somatostatin analogs are an invaluable therapeutic option in the diagnosis and treatment of somatotropinomas, thyrotropinomas, and functioning and non-functioning gastroenteropancreatic neuroendocrine tumors. They should also be considered an effective and safe therapeutic alternative to corticotropinomas, gonadotropinomas, and prolactinomas resistant to dopamine agonists. Somatostatin analogs have also shown to be useful in the treatment of other endocrine diseases (congenital hyperinsulinism, Graves’ orbitopathy, diabetic retinopathy, diabetic macular edema), non-endocrine tumors (breast, colon, prostate, lung, and hepatocellular), and digestive diseases (chronic refractory diarrhea, hepatorenal polycystosis, gastrointestinal hemorrhage, dumping syndrome, and intestinal fistula).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone
Brazeau, P., Vale, W., Burgus, R., Ling, N., Butcher, M., Rivier, J., & Guillemin, R. (1973) · Science · doi:10.1126/science.179.4068.77 · Cited by 3,532
Rinke, A., Müller, H.-H., Schade-Brittinger, C., Klose, K.-J., Barth, P., Wied, M., Mayer, C., Aminossadati, B., Pape, U.-F., Bläker, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.8510 · Cited by 2,508
Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
Caplin, M. E., Pavel, M., Ćwikła, J. B., Phan, A. T., Raderer, M., Sedláčková, E., Cadiot, G., Wolin, E. M., Capdevila, J., Wall, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1316158 · Cited by 1,935
Acromegaly: An Endocrine Society Clinical Practice Guideline
Katznelson, L., Laws, E. R., Melmed, S., Molitch, M. E., Murad, M. H., Utz, A., & Wass, J. A. H. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2700 · Cited by 1,786
Somatostatin and Its Receptor Family
Patel, Y. C. (1999) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1999.0183 · Cited by 1,648
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
Trainer, P. J., Drake, W. M., Katznelson, L., Freda, P. U., Herman-Bonert, V., van der Lely, A. J., Dimaraki, E. V., Stewart, P. M., Friend, K. E., Vance, M. L., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004203421604 · Cited by 879
Advances in the Treatment of Prolactinomas
Gillam, M. P., Molitch, M. E., Lombardi, G., & Colao, A. (2006) · Endocrine Reviews · doi:10.1210/er.2005-9998 · Cited by 824
Pharmacological Treatment of Portal Hypertension: An Evidence-Based Approach
D'Amico, G., Pagliaro, L., & Bosch, J. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007133 · Cited by 782
Bruns, C., Lewis, I., Briner, U., Meno-Tetang, G., & Weckbecker, G. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460707 · Cited by 692
A 12-month phase 3 study of pasireotide in Cushing's disease
Colao, A., Petersenn, S., Newell-Price, J., Findling, J. W., Gu, F., Maldonado, M., Schoenherr, U., Dipl.-Biol., Mills, D., Salgado, L. R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105743 · Cited by 628
Long-Term Mortality after Transsphenoidal Surgery and Adjunctive Therapy for Acromegaly1
Swearingen, B., Barker, F. G., Katznelson, L., Biller, B. M. K., Grinspoon, S., Klibanski, A., Moayeri, N., Black, P. M., & Zervas, N. T. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.10.5222 · Cited by 586
Öberg, K., Kvols, L., Caplin, M., Delle Fave, G., de Herder, W., Rindi, G., Ruszniewski, P., Woltering, E. A., & Wiedenmann, B. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh216 · Cited by 577
Chatzellis, E., Alexandraki, K. I., Androulakis, I. I., & Kaltsas, G. (2015) · Neuroendocrinology · doi:10.1159/000371806 · Cited by 572
Genetic Analysis of Italian Patients with Congenital Hyperinsulinism of Infancy
Sogno Valin, P., Proverbio, M. C., Diceglie, C., Gessi, A., di Candia, S., Mariani, B., Zamproni, I., Mangano, E., Asselta, R., Battaglia, C., et al. (2013) · Hormone Research in Paediatrics · doi:10.1159/000350827 · Cited by 552
The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical ‘cure’
Nomikos, P., Buchfelder, M., & Fahlbusch, R. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01863 · Cited by 500
Thyrotropin-Secreting Pituitary Tumors*
BECK-PECCOZ, P., BRUCKER-DAVIS, F., PERSANI, L., SMALLRIDGE, R. C., & WEINTRAUB, B. D. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-6-610 · Cited by 491
MODLIN, I. M., PAVEL, M., KIDD, M., & GUSTAFSSON, B. I. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04174.x · Cited by 410
Expert consensus document: A consensus on the medical treatment of acromegaly
Giustina, A., Chanson, P., Kleinberg, D., Bronstein, M. D., Clemmons, D. R., Klibanski, A., van der Lely, A. J., Strasburger, C. J., Lamberts, S. W., Ho, K. K. Y., et al. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.21 · Cited by 407
Long-Term Mortality after Transsphenoidal Surgery and Adjunctive Therapy for Acromegaly
Swearingen, B. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.10.3419 · Cited by 400
Gadelha, M. R., Bronstein, M. D., Brue, T., Coculescu, M., Fleseriu, M., Guitelman, M., Pronin, V., Raverot, G., Shimon, I., Lievre, K. K., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70169-x · Cited by 396
Rubin, J., Ajani, J., Schirmer, W., Venook, A. P., Bukowski, R., Pommier, R., Saltz, L., Dandona, P., & Anthony, L. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.600 · Cited by 389
Transsphenoidal Microsurgery for Cushing Disease: A Report of 216 Cases
Mampalam, T. J., Tyrrell, J. B., & Wilson, C. B. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-6-487 · Cited by 386
Angiogenic and Antiangiogenic Factors in Proliferative Diabetic Retinopathy
Simo, R., Carrasco, E., Garcia-Ramirez, M., & Hernandez, C. (2006) · Current Diabetes Reviews · doi:10.2174/157339906775473671 · Cited by 364
Buscail, L., Delesque, N., Estève, J. P., Saint-Laurent, N., Prats, H., Clerc, P., Robberecht, P., Bell, G. I., Liebow, C., & Schally, A. V. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2315 · Cited by 327
The Glucagonoma Syndrome Clinical and Pathologic Features in 21 Patients
Wermers, R. A., Fatourechi, V., Wynne, A. G., Kvols, L. K., & Lloyd, R. V. (1996) · Medicine · doi:10.1097/00005792-199603000-00002 · Cited by 322
Brücker-Davis, F., Oldfield, E. H., Skarulis, M. C., Doppman, J. L., & Weintraub, B. D. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.2.476 · Cited by 311
Møller, L. N., Stidsen, C. E., Hartmann, B., & Holst, J. J. (2003) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(03)00235-9 · Cited by 307
Rationale for the use of somatostatin analogs as antitumor agents
Susini, C., & Buscail, L. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl105 · Cited by 304
Practical management of hyperinsulinism in infancy
Aynsley-Green, A., Hussain, K., Hall, J., Saudubray, J. M., Nihoul-Fékété, C., De Lonlay-Debeney, P., Brunelle, F., Otonkoski, T., Thornton, P., & Lindley, K. J. (2000) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/fn.82.2.f98 · Cited by 298
(2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0050 · Cited by 292
Hofland, L. J., van der Hoek, J., Feelders, R., van Aken, M. O., van Koetsveld, P. M., Waaijers, M., Sprij-Mooij, D., Bruns, C., Weckbecker, G., de Herder, W. W., et al. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01876 · Cited by 276
The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients
Socin, H., Chanson, P., Delemer, B., Tabarin, A., Rohmer, V, Mockel, J., Stevenaert, A., & Beckers, A. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480433 · Cited by 274
Ruggenenti, P., Remuzzi, A., Ondei, P., Fasolini, G., Antiga, L., Ene-Iordache, B., Remuzzi, G., & Epstein, F. H. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00395.x · Cited by 270
Trainer, P. J., Lawrie, H. S., Verhelst, J., Howlett, T. A., Lowe, D. G., Grossman, A. B., Savage, M. O., Afshar, F., & Besser, G. M. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb00975.x · Cited by 267
Diagnosing and Managing Carcinoid Heart Disease in Patients With Neuroendocrine Tumors
Davar, J., Connolly, H. M., Caplin, M. E., Pavel, M., Zacks, J., Bhattacharyya, S., Cuthbertson, D. J., Dobson, R., Grozinsky-Glasberg, S., Steeds, R. P., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.12.030 · Cited by 261
Günther, T., Tulipano, G., Dournaud, P., Bousquet, C., Csaba, Z., Kreienkamp, H.-J., Lupp, A., Korbonits, M., Castaño, J. P., Wester, H.-J., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.015388 · Cited by 253
Effect of Octreotide Pretreatment on Surgical Outcome in Acromegaly
Colao, A., Ferone, D., Cappabianca, P., De, M. D. B., Marzullo, P., Monticelli, A., Alfieri, A., Merola, B., Calì, A., de Divitiis, E., et al. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.10.3308 · Cited by 234
Long-Term Mortality after Transsphenoidal Surgery for Cushing Disease
Swearingen, B., Biller, B. M. K., Barker, F. G., Katznelson, L., Grinspoon, S., Klibanski, A., & Zervas, N. T. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-10-199905180-00015 · Cited by 231
Caplin, M. E., Pavel, M., Ćwikła, J. B., Phan, A. T., Raderer, M., Sedláčková, E., Cadiot, G., Wolin, E. M., Capdevila, J., Wall, L., et al. (2016) · Endocrine-Related Cancer · doi:10.1530/erc-15-0490 · Cited by 230
Octreotide for acute esophageal variceal bleeding: A meta-analysis
Corley, D. A., Cello, J. P., Adkisson, W., Ko, W., & Kerlikowske, K. (2001) · Gastroenterology · doi:10.1053/gast.2001.22451 · Cited by 224
Somatostatin receptor subtype gene expression in pituitary adenomas
Miller, G. M. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.4.1386 · Cited by 220
Wolin, E., Jarzab, B., Eriksson, B., Walter, T., Toumpanakis, C., Morse, M. A., Tomassetti, P., Weber, M. M., Fogelman, D., Ramage, J., et al. (2015) · Drug Design, Development and Therapy · doi:10.2147/dddt.s84177 · Cited by 210
Dumping Syndrome: Pathophysiology and Treatment
Ukleja, A. (2005) · Nutrition in Clinical Practice · doi:10.1177/0115426505020005517 · Cited by 210
Kvols, L. K., Oberg, K. E., O'Dorisio, T. M., Mohideen, P., de Herder, W. W., Arnold, R., Hu, K., Zhang, Y., Hughes, G., Anthony, L., et al. (2012) · Endocrine-Related Cancer · doi:10.1530/erc-11-0367 · Cited by 199
Pharmacologic Resistance in Prolactinoma Patients
Molitch, M. E. (2005) · Pituitary · doi:10.1007/s11102-005-5085-2 · Cited by 194
Delgrange, E., Daems, T., Verhelst, J., Abs, R., & Maiter, D. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0012 · Cited by 194
Greenman, Y. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.3.724 · Cited by 190
Medical therapy for clinically non-functioning pituitary adenomas
Colao, A., Di Somma, C., Pivonello, R., Faggiano, A., Lombardi, G., & Savastano, S. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0181 · Cited by 186
Expression of mRNA for all five human somatostatin receptors (hSSTR1-5) in pituitary tumors
Panetta, R., & Patel, Y. C. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00956-2 · Cited by 185
Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms
Grozinsky-Glasberg, S., Shimon, I., Korbonits, M., & Grossman, A. B. (2008) · Endocrine Related Cancer · doi:10.1677/erc-07-0288 · Cited by 183
Management of Dopamine Agonist-Resistant Prolactinoma
Maiter, D. (2019) · Neuroendocrinology · doi:10.1159/000495775 · Cited by 180
Vezzosi, D., Bennet, A., Rochaix, P., Courbon, F., Selves, J., Pradere, B., Buscail, L., Susini, C., & Caron, P. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01901 · Cited by 179
Somatostatin and Somatostatin Receptor Physiology
Barnett, P. (2003) · Endocrine · doi:10.1385/endo:20:3:255 · Cited by 175
Safety and Efficacy of Oral Octreotide in Acromegaly: Results of a Multicenter Phase III Trial
Melmed, S., Popovic, V., Bidlingmaier, M., Mercado, M., van der Lely, A. J., Biermasz, N., Bolanowski, M., Coculescu, M., Schopohl, J., Racz, K., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4113 · Cited by 173
Cotreatment of Acromegaly with a Somatostatin Analog and a Growth Hormone Receptor Antagonist
Jørgensen, J. O. L., Feldt-Rasmussen, U., Frystyk, J., Chen, J.-W., Kristensen, L. Ø., Hagen, C., & Ørskov, H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0531 · Cited by 173
Therapeutic uses of somatostatin and its analogues: Current view and potential applications
Rai, U., Thrimawithana, T. R., Valery, C., & Young, S. A. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.05.007 · Cited by 168
Saveanu, A., Gunz, G., Dufour, H., Caron, P., Fina, F., Ouafik, L., Culler, M. D., Moreau, J. P., Enjalbert, A., & Jaquet, P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7099 · Cited by 168
Treatment of Type II Gastric Carcinoid Tumors with Somatostatin Analogues
Tomassetti, P., Migliori, M., Caletti, G. C., Fusaroli, P., Corinaldesi, R., & Gullo, L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008243430805 · Cited by 166
Congenital Hyperinsulinism: Diagnosis and Treatment Update
Demirbilek, H., & Hussain, K. (2018) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.2017.s007 · Cited by 163
Ruszniewski, P. B., Ish‐Shalom, S., Wymenga, M., O’Toole, D., Arnold, R., Tomassetti, P., Bax, N., Caplin, M. E., Eriksson, B. K., Gläser, B., et al. (2004) · Neuroendocrinology · doi:10.1159/000082875 · Cited by 154
Novel pathway for somatostatin analogs in patients with acromegaly
Gadelha, M. R., Kasuki, L., & Korbonits, M. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.11.007 · Cited by 153
Conventional and Nuclear Medicine Imaging in Ectopic Cushing's Syndrome: A Systematic Review
Isidori, A. M., Sbardella, E., Zatelli, M. C., Boschetti, M., Vitale, G., Colao, A. A. L., Pivonello, R., * ABC (Altogether to Beat Cushing's syndrome) 2013 Group collaborators, Albiger, N. M. E., Ambrogio, A. G., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1589 · Cited by 151
Therapeutic Options for Gastrointestinal Carcinoids
Modlin, I. M., Latich, I., Kidd, M. S., Zikusoka, M. N., & Eick, G. N. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2005.12.008 · Cited by 148
van der Hoek, J., de Herder, W. W., Feelders, R. A., van der Lely, A. J., Uitterlinden, P., Boerlin, V., Bruns, C., Poon, K. W., Lewis, I., Weckbecker, G., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031052 · Cited by 144
Panzuto, F., Fonzo, M. D., Iannicelli, E., Sciuto, R., MAINI, C. L., Capurso, G., Milione, M., Cattaruzza, M. S., Falconi, M., David, V., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdj113 · Cited by 138
Thyrotropin-Secreting Pituitary Tumors
Samuels, M. H. (1997) · Humana Press eBooks · doi:10.1007/978-1-4612-3954-3_15 · Cited by 125
Treatment of gastroenteropancreatic neuroendocrine tumours with octreotide LAR
Tomassetti, Migliori, Corinaldesi, & Gullo (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00738.x · Cited by 125
Becker, G., Allgaier, H., Olschewski, M., Zähringer, A., & Blum, H. E. (2006) · Hepatology · doi:10.1002/hep.21468 · Cited by 125
Caron, P. J., Arlot, S., Bauters, C. C., Chanson, P., Kuhn, J., PUGEAT, M. M., Maréchaud, R., Teutsch, C., Vidal, E., & Sassano, P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7593 · Cited by 119
Diagnosis and Management of Hyperinsulinaemic Hypoglycaemia of Infancy
Hussain, K. (2007) · Hormone Research in Paediatrics · doi:10.1159/000111789 · Cited by 119
Association Between Somatostatin Receptor Expression and Clinical Outcomes in Neuroendocrine Tumors
Qian, Z. R., Li, T., Ter‐Minassian, M., Yang, J., Chan, J. A.-W., Brais, L. K., Masugi, Y., Thiaglingam, A., Brooks, N. V., Nishihara, R., et al. (2016) · Pancreas · doi:10.1097/mpa.0000000000000700 · Cited by 114
Papotti, M. G., Croce, S., Bellò, M., Bongiovanni, M., Allìa, E., Schindler, M., & Bussolati, G. (2001) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280100494 · Cited by 108
Prolactinomas resistant to bromocriptine: long-term efficacy of quinagolide and outcome of pregnancy
Morange, I., Barlier, A., Pellegrini, I., Brue, T. C., Enjalbert, A., & Jaquet, P. (1996) · European Journal of Endocrinology · doi:10.1530/eje.0.1350413 · Cited by 104
Epidemiology and Management Challenges in Prolactinomas
Vroonen, L., Daly, A., & Beckers, A. M. (2019) · Neuroendocrinology · doi:10.1159/000497746 · Cited by 102
Efficacy of Octreotide Acetate in Treatment of Severe Postgastrectomy Dumping Syndrome
Geer, R. J., Richards, W. O., O’Dorisio, T. M., WOLTERING, E. O., Williams, S. T., Rice, D. E., & Abumrad, N. N. (1990) · Annals of Surgery · doi:10.1097/00000658-199012000-00005 · Cited by 100
New somatostatin analogs: will they fulfil old promises?
Lamberts, S., van der Lely, A., & Hofland, L. J. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460701 · Cited by 100
Vinik, A. I., Wolin, E. M., Liyanage, N., Gomez-Panzani, E. L., & Fisher, G. A. (2016) · Endocrine Practice · doi:10.4158/ep151172.or · Cited by 100
Octreotide potentiates PKC-dependent vasoconstrictors in portal-hypertensive and control rats
Wiest, R., Tsai, M., & Groszmann, R. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.22529 · Cited by 98
Somatostatinergic systems: an update on brain functions in normal and pathological aging
Martel, G., Dutar, P., Epelbaum, J., & Viollet, C. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00154 · Cited by 96
Imperiale, T. F., Teran, J. C., & McCullough, A. J. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90590-1 · Cited by 96
Use of the somatostatin analogue octreotide to localise and manage somatostatin-producing tumours
Angeletti, S., Corleto, V. D., Schillaci, O., Marignani, M., Annibale, B., Moretti, A., Silecchia, G., Scopinaro, F., Basso, N., Bordi, C., et al. (1998) · Gut · doi:10.1136/gut.42.6.792 · Cited by 93
The Effect of Somatostatin versus Corticosteroid in the Treatment of Graves' Ophthalmopathy
Kung, A. W. C., Michon, J., Tai, K. S., & Chan, F. L. (1996) · Thyroid · doi:10.1089/thy.1996.6.381 · Cited by 88
Differences in the degradation of hypothalamic releasing factors by rat and human serum
Benuck, M., & Marks, N. (1976) · Life Sciences · doi:10.1016/0024-3205(76)90263-0 · Cited by 84
Trainer, P. J. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0322 · Cited by 84
Terlipressin for the treatment of acute variceal bleeding
Zhou, X., Tripathi, D., Song, T., Shao, L., Han, B., Zhu, J. Y., Han, D., Liu, F., & Qi, X. (2018) · Medicine · doi:10.1097/md.0000000000013437 · Cited by 80
Glycoprotein hormone α-subunit in pituitary adenomas
Beck‐Peccoz, P., Persani, L., & Faglia, G. (1992) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(92)90041-x · Cited by 78
CCK‐B/gastrin receptors in human colorectal cancer
Schmitz, F., Otte, J. ‐., Stechele, H. U., Reimann, B., Banasiewicz, T., Fölsch, U. R., Schmidt, W. E., & Herzig, K. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00870.x · Cited by 74
Ezzat, S., Horváth, É., Kovács, K., et al. (1995) · Endocrine Pathology · doi:10.1007/bf02739875 · Cited by 68
Faggiano, A., Modica, R., Calzo, F. L., Camera, L., Napolitano, V., Altieri, B., de Cicco, F., Bottiglieri, F., Sesti, F. F., Badalamenti, G., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz007 · Cited by 64
Lamberts, S. W. J., de Herder, W. W., Krenning, E. P., & Reubi, J. C. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.1.7904612 · Cited by 63
Chaidarun, S., & Klibanski, A. (2002) · Seminars in Reproductive Medicine · doi:10.1055/s-2002-36708 · Cited by 63
Medical therapy of pituitary adenomas: Effects on tumor shrinkage
Colao, A., Pivonello, R., Somma, C. D., Savastano, S., Grasso, L. F. S., & Lombardi, G. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9107-z · Cited by 62
Clinically non-functioning pituitary adenomas: Pathogenic, diagnostic and therapeutic aspects
Mercado, M., Melgar, V., Salame, L., & Cuenca, D. (2017) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2017.05.009 · Cited by 61
Use of octreotide acetate for control of symptoms in patients with islet cell tumors
Maton, P. N. (1993) · World Journal of Surgery · doi:10.1007/bf01655110 · Cited by 57
Delgrange, E., Duprez, T. P. J., & Maiter, D. M. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02493.x · Cited by 53
Systematic review: the use of somatostatin or octreotide in refractory diarrhoea
Szilagyi, A., & Shrier, I. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01114.x · Cited by 52
Somatostatin and the dumping syndrome.
Long, R. G., Adrian, T. E., & Bloom, S. R. (1985) · BMJ · doi:10.1136/bmj.290.6472.886 · Cited by 50
Preliminary data on biochemical remission of acromegaly after somatostatin analogs withdrawal
Ronchi, C. L., Rizzo, E., Lania, A. G., Pivonello, R., Grottoli, S., Colao, A., Ghigo, E., Spada, A., Arosio, M., & Beck‐Peccoz, P. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0488 · Cited by 50
Efficacy of depot long‐acting release octreotide therapy in severe dumping syndrome
PENNING, C., VECHT, J., & MASCLEE, A. A. M. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02681.x · Cited by 48
Ramundo, V., Prete, M. D., Marotta, V., et al. (2014) · Clinical Endocrinology · doi:10.1111/cen.12411 · Cited by 48
Pasireotide for malignant insulinoma
Tirosh, A., Stemmer, S. M., Solomonov, E., Elnekave, E., Saeger, W., Ravkin, Y., Nir, K., Talmor‐Barkan, Y., & Shimon, I. (2015) · HORMONES · doi:10.14310/horm.2002.1639 · Cited by 48
van Hoek, M., Hofland, L. J., de Rijke, Y. B., van Nederveen, F. H., de Krijger, R. R., van Koetsveld, P. M., Lamberts, S. W. J., van der Lely, A. J., de Herder, W. W., & Feelders, R. A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1712 · Cited by 47
Excellent response to pasireotide therapy in an aggressive and dopamine-resistant prolactinoma.
Coopmans, E. C., van Meyel, S. V., Pieterman, K., van Ipenburg, J. V., Hofland, L., Donga, E., Daly, A., Beckers, A., van der Lely, A. J., & Neggers, S. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0279 · Cited by 47
Fleseriu, M., Petersenn, S., Biller, B. M. K., Kadıoğlu, P., Block, C. E. M. D., T'Sjoen, G. G., Vantyghem, M., Tauchmanovà, L., Wojna, J., Roughton, M., et al. (2019) · Clinical Endocrinology · doi:10.1111/cen.14081 · Cited by 46
Is there a role for somatostatin and its analogs in Cushing's syndrome?
de Herder, W. W., & Lamberts, S. W. J. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90091-8 · Cited by 44
Li-Ling, J., & Irving, M. H. (2001) · Postgraduate Medical Journal · doi:10.1136/pmj.77.909.441 · Cited by 44
Ruszniewski, P. B., Valle, J. W., Lombard‐Bohas, C., Cuthbertson, D. J., Perros, P., Holubec, L., Fave, G. D., Smith, D. M., Niccoli, P., Maisonobe, P., et al. (2016) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.12.013 · Cited by 44
Lamberti, G., Faggiano, A., Brighi, N., Tafuto, S., Ibrahim, T., Brizzi, M. P., Pusceddu, S., Albertelli, M., Massironi, S., Panzuto, F., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz035 · Cited by 44
Gadelha, M. R., Bex, M., Colao, A. A. L., García, E. M. P., Poiană, C., Sánchez, M. J., Yener, S., Mukherjee, R., Bartalotta, A., Maamari, R., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00931 · Cited by 44
The safety of available treatments options for neuroendocrine tumors
Faggiano, A., Calzo, F. L., Pizza, G., Modica, R., & Colao, A. A. L. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1354984 · Cited by 43
Somatostatin inhibits colon cancer cell growth through cyclooxygenase‐2 downregulation
Colucci, R., Blandizzi, C., Ghisu, N., Florio, T., & Tacca, M. D. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.268 · Cited by 41
Hyer, S. L., Sharp, P. S., Brooks, R. A., Burrin, J. M., & KOHNER, E. M. (1989) · European Journal of Endocrinology · doi:10.1530/acta.0.1200187 · Cited by 41
Control of dumping symptoms by somatostatin analogue in patients after gastric surgery.
Gray, J., Debas, H., & Mulvihill, S. (1991) · Archives of Surgery · doi:10.1001/archsurg.1991.01410340073010 · Cited by 39
Somatostatin Analogs in Treatment of Non-Growth Hormone-Secreting Pituitary Adenomas
Colao, A. A. L., Filippella, M., Somma, C. D., Manzi, S., Rota, F., Pivonello, R., Gaccione, M., Rosa, M. D., & Lombardi, G. (2003) · Endocrine · doi:10.1385/endo:20:3:279 · Cited by 39
Endocrine inactive and gonadotroph adenomas: diagnosis and management
Losa, M., Mortini, P., Barzaghi, L. R., Franzin, A., & Giovanelli, M. A. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1012965617685 · Cited by 37
Safety and efficacy of pasireotide in dumping syndrome—results from a phase 2, multicentre study
Tack, J. F., Aberle, J., Arts, J., Laville, M., Oppert, J., Bender, G., Bhoyrul, S., McLaughlin, T., Yoshikawa, T., Vella, A., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14664 · Cited by 37
Clinically non-functioning pituitary adenomas: Pathogenic, diagnostic and therapeutic aspects
Mercado, M., Melgar, V., Salame, L., & Cuenca, D. (2017) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2017.08.012 · Cited by 37
Wang, C., Han, J., Xiao, L., Jin, C., Li, D., & Yang, Z. (2014) · Hepatology International · doi:10.1007/s12072-014-9594-9 · Cited by 35
Combined treatment of somatostatin analogues with pegvisomant in acromegaly
Franck, S. E., Muhammad, A., van der Lely, A. J., & Neggers, S. (2015) · Endocrine · doi:10.1007/s12020-015-0810-8 · Cited by 29
Cuny, T., Mohamed, A., Graillon, T., Roche, C., Defilles, C., Germanetti, A. L., Couderc, B. C., Figarella-Branger, D. F., Enjalbert, A., Barlier, A., et al. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.01.026 · Cited by 27
Zarogoulidis, P., Eleftheriadou, E., Kontakiotis, T., Gerasimou, G., Zarogoulidis, P., Sapardanis, I., Galaktidou, G., Sakkas, L., Gotzamani‐Psarrakou, A., & Karatzas, N. D. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.09.014 · Cited by 27
Laskaratos, F., Walker, M., Naik, K., Maragkoudakis, E., Oikonomopoulos, N., Grant, L. A., Meyer, T., Caplin, M. E., & Toumpanakis, C. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.349 · Cited by 26
Kuhn, J., Basin, C., Mollard, M., de Rougé, B., Baudoin, C., Obach, R., & Tolis, G. (1993) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315353 · Cited by 24
Treatment of Zollinger-Ellison Syndrome
Tomassetti, P. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i35.5423 · Cited by 22
Octreotide improves early dumping syndrome potentially through incretins: a case report
Sato, D., Morino, K., Ohashi, N., Ueda, E., Ikeda, K., Yamamoto, H., Ugi, S., Yamamoto, H., Araki, S., & Maegawa, H. (2013) · Endocrine Journal · doi:10.1507/endocrj.ej12-0288 · Cited by 21
The Place of Octreotide in the Medical Management of the Dumping Syndrome
Scarpignato, C. (2009) · Digestion · doi:10.1159/000201413 · Cited by 20
Phase I dose-escalation study of long-acting pasireotide in patients with neuroendocrine tumors
Yao, J. C., Chan, J. A., Mita, A. C., Kundu, M. G., Reséndiz, K. H., Hu, K., Ravichandran, S., Strosberg, J., & Wolin, E. M. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s128547 · Cited by 20
Chanson, P., & Maiter, D. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804169-7.00016-7 · Cited by 18
Somatostatin and diabetic retinopathy: an evolving story
Simó‐Servat, O., Hernández, C., & Simó, R. (2018) · Endocrine · doi:10.1007/s12020-018-1561-0 · Cited by 16
Neurosurgical Treatment of Acromegaly
Buchfelder, M., & Feulner, J. (2016) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.11.002 · Cited by 10
Luque‐Ramírez, M., Carreño, Á., Álvarez‐Escolá, C., Picó, C. D. P., da Costa, C. V., Fajardo, C., Gilabert, M., & Webb, S. M. (2011) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2011.09.002 · Cited by 7
Self-citationMarciello, F. (2013) · Journal of Genetic Syndromes & Gene Therapy · doi:10.4172/2157-7412.1000179 · Cited by 2
Wajchenberg (2000) · doi:10.1002/(sici)1097-0142(20000215)88:4
Cited by
Enteric neuropathy in diabetes: Implications for gastrointestinal function
Abdalla, M. M. I. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i22.2852 · Cited by 45
Metadata
- Authors
- Gomes-Porras, M., Cárdenas-Salas, J., & Álvarez-Escolá, C.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-02-29
- Volume
- 21
- Issue
- 5
- Pages
- 1682
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3009711324
- Cited by
- 264
- References
- 134
- FWCI
- 20.74
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.